SMID Cap Biotech Analyst Rama holds a conference call with CEO Wong to be held on April 17 at 11 am hosted by JPMorgan. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RAPT:
- Capital One remains bullish on RPT193 as Rapt initiates Phase 2a Asthma study
- Rapt Therapeutics announces initiation of Phase 2a trial of RPT193
- Cantor biopharma/biotech analysts hold analyst/industry conference call
- Biotech Alert: Searches spiking for these stocks today
- Rapt outlook ‘remains steady’ despite shift in timeline, says Capital One